WallStSmart

Healthcare Triangle Inc (HCTI)vsVeeva Systems Inc Class A (VEEV)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Veeva Systems Inc Class A generates 13369% more annual revenue ($3.46B vs $25.67M). VEEV leads profitability with a 29.3% profit margin vs -66.3%. VEEV earns a higher WallStSmart Score of 66/100 (B-).

HCTI

Hold

41

out of 100

Grade: D

Growth: 5.3Profit: 2.0Value: 5.0Quality: 4.5
Piotroski: 3/9Altman Z: -2.84

VEEV

Strong Buy

66

out of 100

Grade: B-

Growth: 8.7Profit: 8.0Value: 6.7Quality: 9.0
Piotroski: 4/9Altman Z: 4.78
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for HCTI.

VEEVUndervalued (+41.1%)

Margin of Safety

+41.1%

Fair Value

$300.79

Current Price

$278.57

$22.22 discount

UndervaluedFair: $300.79Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HCTI3 strengths · Avg: 9.7/10
Price/BookValuation
0.1x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
158.4%10/10

Revenue surging 158.4% year-over-year

Debt/EquityHealth
0.269/10

Conservative balance sheet, low leverage

VEEV6 strengths · Avg: 8.8/10
Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.7810/10

Safe zone — low bankruptcy risk

Profit MarginProfitability
29.3%9/10

Keeps 29 of every $100 in revenue as profit

Operating MarginProfitability
29.6%8/10

Strong operational efficiency at 29.6%

Revenue GrowthGrowth
17.6%8/10

17.6% revenue growth

EPS GrowthGrowth
39.5%8/10

Earnings expanding 39.5% YoY

Areas to Watch

HCTI4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$11.39M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-26.5%2/10

ROE of -26.5% — below average capital efficiency

VEEV1 concerns · Avg: 2.0/10
P/E RatioValuation
42.7x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : HCTI

The strongest argument for HCTI centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 158.4% demonstrates continued momentum.

Bull Case : VEEV

The strongest argument for VEEV centers on Debt/Equity, Altman Z-Score, Profit Margin. Profitability is solid with margins at 29.3% and operating margin at 29.6%. Revenue growth of 17.6% demonstrates continued momentum.

Bear Case : HCTI

The primary concerns for HCTI are EPS Growth, Market Cap, Piotroski F-Score.

Bear Case : VEEV

The primary concerns for VEEV are P/E Ratio. A P/E of 42.7x leaves little room for execution misses.

Key Dynamics to Monitor

HCTI profiles as a hypergrowth stock while VEEV is a growth play — different risk/reward profiles.

HCTI carries more volatility with a beta of 1.09 — expect wider price swings.

HCTI is growing revenue faster at 158.4% — sustainability is the question.

VEEV generates stronger free cash flow (231M), providing more financial flexibility.

Bottom Line

VEEV scores higher overall (66/100 vs 41/100), backed by strong 29.3% margins and 17.6% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Healthcare Triangle Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Healthcare Triangle, Inc. is a healthcare information technology company. The company is headquartered in Pleasanton, California.

Veeva Systems Inc Class A

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. The company is headquartered in Pleasanton, California.

Visit Website →

Want to dig deeper into these stocks?